HCWB

Latest SEC Filings & News for HCWB

2 most recent filings and news items mentioning HCWB. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/HCWB/news?limit=20"

Pull HCWB filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 16, 2026Positive

HCW Biologics reports positive Phase 1 data for IL-2 immunotherapy HCW9302 in alopecia areata

HCW Biologics announced positive preliminary results from its Phase 1 clinical trial of HCW9302, with all three patients in the second dose cohort showing ≥25% improvement in alopecia severity scores and no dose-limiting toxicities reported. The well-tolerated results support the

View filing at SEC.gov →

OtherMay 27, 2026Positive

HCW Biologics Regains Full Rights to CAR-T Reagents from Wugen

HCW Biologics exercised its option to regain exclusive ex vivo rights to HCW9206 and HCW9201 compounds from Wugen at no cost while retaining upfront fees including 2.2M Wugen shares. The move positions the company to commercialize CAR-T manufacturing reagents that published data

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.